down arrow

AIM Vaccine Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005KF2
HKD
1.68
-0.02 (-0.88%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Wuxi Biologics (Cayman), Inc.
3SBio, Inc.
Alphamab Oncology
CSPC Pharmaceutical Group Ltd.
Sirnaomics Ltd.
Zai Lab Ltd.
Ascentage Pharma Group International Co., Ltd.
Laekna, Inc.
Beijing Lüzhu Biotechnology Co., Ltd.
AIM Vaccine Co., Ltd.
Genscript Biotech Corp.

Why is AIM Vaccine Co., Ltd. ?

1
High Debt company with Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate 25.92% of over the last 5 years
  • The company is Net-Debt Free
2
Negative results in Jun 26
  • CASH AND EQV(HY) Lowest at HKD 223.27 MM
  • DEBT-EQUITY RATIO (HY) Highest at 59.83 %
  • DEBTORS TURNOVER RATIO(HY) Lowest at 0.83 times
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -60.40%, its profits have risen by 11.5%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -60.40% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is AIM Vaccine Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
AIM Vaccine Co., Ltd.
-60.56%
-1.16
65.15%
Hang Seng Hong Kong
-4.77%
-0.26
18.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-1.72%
EBIT Growth (5y)
25.92%
EBIT to Interest (avg)
-4.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.21
Tax Ratio
1.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.27
EV to EBIT
-10.53
EV to EBITDA
-44.51
EV to Capital Employed
0.52
EV to Sales
1.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.89%
ROE (Latest)
-7.67%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
NET PROFIT(HY)

Higher at HKD -140.01 MM

EPS(Q)

Highest at HKD -0.11

-6What is not working for the Company
CASH AND EQV(HY)

Lowest at HKD 223.27 MM

DEBT-EQUITY RATIO (HY)

Highest at 59.83 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.83 times

NET SALES(Q)

Lowest at HKD 399.72 MM

INTEREST(Q)

Highest at HKD 34.86 MM

Here's what is working for AIM Vaccine Co., Ltd.

Net Profit
Higher at HKD -140.01 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

EPS
Highest at HKD -0.11
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Depreciation
At HKD 92.94 MM has Grown at 10.53%
period on period (QoQ)
MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for AIM Vaccine Co., Ltd.

Net Sales
Lowest at HKD 399.72 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Net Sales
Fallen at -27.7%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Interest
Highest at HKD 34.86 MM
in the last five periods and Increased by 8.38% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Cash and Eqv
Lowest at HKD 223.27 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 59.83 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 0.83 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Footer loading